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A B S T R A C T
The aim of this study was to evaluate the safety and effectiveness of coblation-channeling in the treatment of inferior
turbinate hypertrophy. The study was conducted in the Department of ENT, Head and Neck Surgery, Split University
Hospital Center, Split, Croatia. Fifty-two patients with inferior turbinate hypertrophy who were refractory to medical therapy
were evaluated for coblation. The procedures were performed under local anesthesia using an ArthroCare ReFlexUltra
45 wand; three submucosal channels were made per turbinate. Clinical examinations, a questionnaire on individual na-
sal symptoms (hyposmia, nasal drainage and post-nasal drip), a 10-cm visual analog scale (VAS) grading general nasal
obstructions, and rhinomanometry before and 8 weeks after the treatment were administered to assess treatment out-
comes. No adverse effects were encountered. Nasal breathing was significantly improved in all patients, decreasing the
VAS from a median of 7 (range 2–9) to 1 (range 0–3) (p<0.001). Total nasal resistance decreased from 0.44 Pa±0.50 to
0.24 Pa±0.11 (p=0.005). Improvement was statistically significant for all three symptoms (hyposmia [p=0.005], nasal
drainage [p=0.003] and post-nasal drip [p<0.001]). In this paper, we demonstrate that coblation-channeling of the hy-
pertrophic inferior turbinate is an effective and safe way to reduce nasal obstruction symptoms.
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Introduction
Nasal obstruction is one of the oldest and most com-
mon human complaints, and hypertrophy of the inferior
turbinate is a common cause of chronic nasal obstruc-
tion1.
Nasal obstruction is a considerable handicap for pa-
tients and drastically affects their quality of life. Inferior
turbinate hypertrophy is usually observed with septal de-
viations (compensatory hypertrophy) and is associated
with chronic rhinitis2.
Epidemiologic investigations in various European coun-
tries have shown that up to 20% of the population has a
chronic nasal obstruction caused by turbinate hypertro-
phy2,3. However, there is no agreement on how to treat
this problem. Pharmacological therapy (using intranasal
topical steroids, antihistamines or decongestants) is gen-
erally the treatment of choice4. Nasal breathing is often
only slightly improved by conservative treatments, com-
pelling patients to use local decongestants with a high
risk of undesirable side effects2. In these cases, surgical
reduction of the turbinate is an available option2–4.
At least 13 different techniques have been introduced
since the last quarter of the 19th century (e.g., total or
partial turbinectomy, laser-assisted turbinoplasty, cryo-
surgery, electrocautery using monopolar and bipolar tech-
niques, radio-frequency volumetric tissue reduction and
microdebrider submucosal reduction)1,2,4–6. The variety
of available surgical techniques indicates a lack of con-
sensus on the optimal technique2.
The majority of these techniques provide satisfactory
results in terms of diminishing nasal obstruction, but ad-
verse events are frequently observed. Bleeding, crusting,
foul odor, pain, hyposmia, synechia, bone necrosis and in-
fection are mainly caused by mucosal lesions that impair
nasal mucociliary function1,2,5,7.
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The ideal procedure for turbinate reduction should
improve nasal breathing with minimal discomfort or ad-
verse reactions and should preserve the physiological
function of the turbinates1,2,8. Several studies have report-
ed that the use of radio-frequency energy for submucosal
tissue ablation of the inferior turbinate can meet these
goals1–3,6–15. The tissue response, as well as the extent of
volume reduction caused by radio frequencies, was stud-
ied by Powel et al. in the porcine tongue16. The safety and
efficacy of radio frequencies in the human airway have
been confirmed in soft palate and tonsillar tissue17,18.
The procedure can be repeated without adverse effects
to maintain the best possible results19,20.
We performed a prospective study on the efficacy and
safety of coblation for turbinate reduction. We used not
only subjective symptoms but an objective test as well to
assess the efficacy of coblation in treating nasal obstruc-
tions attributable to turbinate hypertrophy.
Subjects and Methods
Between June 2004 and June 2008, 52 patients with
nasal obstructions due to inferior turbinate hypertrophy
were enrolled in this prospective study. Exclusion criteria
included septal deformation, nasal polyposis and recent
nasal surgery. All patients had been previously treated with
conventional medical management without improvement.
Before treatment, each patient underwent a medical
history and clinical examination. Patients graded their
nasal obstruction on a 10-cm visual analog scale (VAS). A
score of 0 represented no obstruction, and a score of 10
indicated complete obstruction. The patients also com-
pleted a questionnaire measuring the severity of addi-
tional symptoms: hyposmia, nasal drainage and post-nasal
drip, with scores ranging from 0 to 2 (0 – no symptoms, 1
– mild to moderate, 2 – severe). These scores served as
the baseline measurements of nasal symptomatology.
Each patient underwent active anterior rhinomano-
metry (Rhinomanometer 300, ATMOS, Germany), which
assesses trans-nasal resistance depending on the trans-
nasal pressure difference, DP (Pa), between the nostrils
and the choanae. The reference value of each measure-
ment was defined as the resistance at a trans-nasal pres-
sure of 150 kPa.
Operations were performed in an out-patient facility
with patients under local anesthesia from an injection of
2 ccm of 2% lidocaine into each inferior turbinate. All sur-
gical procedures were performed by the same surgeon
(Z.R.) using an ArthroCare ReFlex Ultra 45 Wand (Arthro-
Care Corp., Sunnyvale, CA, USA) to make three submuco-
sal channels per turbinate (power: 6 W for each channel).
Patients were discharged after two hours with instruc-
tions to perform a post-operative treatment of a saline la-
vage twice daily to prevent crusting and dryness and
were advised to continue with their usual daily activities.
Follow-up visits were conducted at two and eight
weeks after the operation to assess early adverse events.
At the week-eight visit, patients completed the VAS and
the nasal questionnaire again to help us determine their
subjective response to the therapy. Rhinomanometry was
also performed after eight weeks to determine the objec-
tive results of the coblation therapy.
This study was approved by the Split University Hos-
pital Medical Ethics Committee.
Statistical analysis
The Statistica 7.1 software package (Stat Soft, Inc.,
Tulsa, USA) was used to statistically analyze the data.
Differences between the total nasal resistance before and
after the operation were statistically evaluated with t-tests
for dependent samples. The Wilcoxon Signed-Rank test
was used to evaluate the differences between nasal symp-
tom scores before and after the operation. The Friedman
test was used to analyze the VAS data. A P-value of less
than 0.05 was considered statistically significant.
Results
Between June 2004 and June 2008, 52 patients (27
men and 25 women) with a mean age of 28.5 years
(range: 11 to 71 years) were enrolled in this trial.
Patients tolerated the procedure well. None of them
felt discomfort during coblation due to overheating of the
tissue. No significant epistaxis occurred during or after
the procedure. Mild crusting was noted in three (5.7%)
patients at the week-two follow-up visit; in these cases,
crusting was observed in the head of the inferior tur-
binate, corresponding to the areas that were punctured
to introduce the wand. None of the patients experienced
adverse events, including bleeding, crusting, dryness, in-
fection, adhesion, or a worsening of obstruction, at the
week-eight follow-up visit.
Nasal breathing was significantly improved in all pa-
tients: the median VAS decreased from 7 (range 2–9) to 1
(range 0–3) (p<0.001, Figure 1). Total nasal resistance
decreased from 0.44 Pa±0.50 to 0.24 Pa±0.11 (p=0.005,
Figure 2).
Patients reported improvement in each of the three
scored symptoms after the procedure. The improvement


















Fig.1. Mean nasal obstruction (VAS) pre- and post-op (8 weeks).
*Significant difference compared to pre-op (p<0.001).
in the symptoms was statistically significant for hypos-
mia (p=0.005), nasal drainage (p=0.003), and post-nasal
drip (p<0.001, Figure 3).
Discussion
The ideal procedure for inferior turbinate reduction
should be performed in an office setting under local anes-
thesia and should require minimal post-operative care,
be clinically effective and preserve the mucosal and glan-
dular architecture of the turbinate. The procedure should
also be repeatable in case inferior turbinate hypertrophy
were to recur9,19.
Despite the existence of various techniques for the
treatment of inferior turbinate enlargement, there is no
consensus in the literature as to which technique is
best1,2,4,5. However, there is a general consensus that
submucosal techniques have advantages in terms of pre-
serving the overall nasal physiology4,5,10.
Coblation seems to meet all of the criteria for an ideal
treatment of inferior turbinate hypertrophy1,6,10–12,15.
In our study, treatment efficacy was confirmed by the
patients’ subjective assessment of their nasal symptoms
(obstruction, hyposmia, nasal drainage and post-nasal
drip) as well as by objective rhinomanometry. The me-
dian VAS decreased from 7 (range 2–9) to 1 (range 0–3)
(p<0.001), which confirms previous reports about the ef-
ficacy of radio frequencies in the literature6,15.
Utley et al.8, Seeger et al.3 and Rhee et al.13 also re-
ported excellent results using radio-frequency submuco-
sal tissue reduction to treat inferior turbinate hypertro-
phy as assessed by subjective scores from patients. In a
placebo-controlled study using radio frequencies, Nease
et al. reported very similar results9.
According to Atef et al., the radio-frequency proce-
dure can be repeated without any additional adverse ef-
fects, thus allowing better long-term results to be main-
tained20. Porter et al. confirmed that good results were
maintained for two years with this procedure11.
In our study, a comparison of rhinomanometry per-
formed before the surgery and eight weeks after the sur-
gery showed a statistically significant difference in nasal
resistance, from 0.44 Pa±0.50 to 0.24 Pa±0.11 (p=0.005),
which is consistent with the acoustic rhinomanometry
results obtained by Fischer et al.14 and Rhee et al.13 after
radio-frequency procedures.
In our study, there were no adverse effects that de-
manded additional surgical treatment. Crusting was not-
ed in three (5.7%) patients at the week-two follow-up
visit and was located in the head of the inferior turbinate,
corresponding to the puncture area where the wand was
introduced. None of the patients reported adverse events
at the week-eight follow-up visit, which confirms previ-
ous safety reports found in the literature3,7,13,14.
Although the vast majority of proposed methods for
the treatment of inferior turbinate enlargement meet
the goal of providing better nasal patency1,2,4,5,19,21, the
main advantage of this technique is its preservation of
the architecture and function of the mucosa1,2.
Conclusions
Coblation channeling of the inferior turbinate is a safe,
highly efficacious procedure for out-patient clinic-based
inferior turbinate reduction. There are no side effects in
either the early or late post-operative periods, and there
is minimal patient discomfort during the procedure.
Thus, coblation tissue reduction of the inferior turbi-
nate meets all of the criteria for an ideal method for the
treatment of inferior turbinate hypertrophy.
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Fig. 2. Rhinomanometry (nasal resistance) pre- and post-op (8
weeks). *Significant difference compared to pre-op (p=0.005).







































Fig. 3. Pre- and post-operative (8 weeks) symptoms.
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U^INKOVITOST I SIGURNOST KOBLACIJSKOG TUNELIRANJA DONJIH NOSNIH [KOLJKI
U LIJE^ENJU NOSNE OPSTRUKCIJE
S A @ E T A K
Cilj ovog istra`ivanja bio je procijeniti u~inkovitost i sigurnost koblacijskog tuneliranja hipertrofi~nih donjih nosnih
{koljki u lije~enju nosne opstrukcije. Studija je provedena u Klinici za bolesti uha, nosa i grla s kirurgijom glave i vrata
KBC Split, Split, Hrvatska. Uklju~ena su 52 pacijenta s hipertrofijom donjih nosnih {koljki refrakternih na konzerva-
tivno lije~enje. Operacije su ra|ene u lokalnoj anesteziji koriste}i ArthoCare ReFlexUltra 45 wand; tri submukozna ka-
nala po svakoj nosnoj {koljki. U procjeni rezultata lije~enja koristili smo: klini~ki pregled, upitnik o individualnim nosnim
simptomima (hiposmija, curenje iz nosa, postnazalni drip), 10-cm vizualno-analognu skalu (VAS) za procjenu nosne
opstrukcije i rinomanometriju prije operacije i 8 tjedana nakon operacije. Tijekom ispitivanja nije zabilje`ena nijedna
nuspojava. Disanje kroz nos se zna~ajno pobolj{alo u svih pacijenata, smanjuju}i VAS od mediana 7 (raspon 2–9) na 1
(raspon 0–3) (p<0,001). Ukupni nosni otpor smanjio se od 0,44 Pa±0,50 na 0,24 Pa±0.11 (p=0,005). Pobolj{anje je bilo
statisti~ki zna~ajno za sva tri individualna simptoma (hiposmija [p=0,005], curenje iz nosa [p=0,003] i postnazalni drip
[p<0,001]). U ovom istra`ivanju pokazali smo da je koblacijsko tuneliranje hipertrofi~nih donjih nosnih {koljki u~inko-
vit i siguran na~in u smanjivanju simptoma nosne opstrukcije.
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